Literature DB >> 14969084

[Tuberculosis control in Kawasaki City--promoting the DOT program].

Yuki Tada1, Masako Ohmori, Kunihiko Ito, Michiko Fujiu.   

Abstract

Kawasaki City initiated the DOT (Directly Observed Therapy) program in 2000 to improve tuberculosis (TB) control in the homeless persons and individuals living in temporary subsidized housing. The program was implemented as an additional program to the city's control policy of mass TB screenings for these groups. The DOT program was implemented through participation of numerous agencies sharing common goals. Through coordination and cooperation, a strategy suitable for the regional level was developed. Sectors involved were not only the TB control staff within the public health centers but also the entire public health centers, the welfare administrative division, the city's TB task force and homeless task force, and regional medical institutions. With the implementation of the DOT program, proper medical treatment, improved patient care, and various other measures were performed, and this led to the strengthening of TB control not only in designated DOT-implemented areas but also in the entire city. As a result, the treatment outcomes improved, and incidence rate of TB began to decrease.

Entities:  

Mesh:

Year:  2004        PMID: 14969084

Source DB:  PubMed          Journal:  Kekkaku        ISSN: 0022-9776


  3 in total

1.  Strengthened tuberculosis control programme and trend of multi-drug resistant tuberculosis rate in Osaka City, Japan.

Authors:  Akira Shimouchi; Akihiro Ohkado; Kenji Matsumoto; Jun Komukai; Hideki Yoshida; Nobukatsu Ishikawa
Journal:  Western Pac Surveill Response J       Date:  2013-02-26

Review 2.  ROLES OF PUBLIC HEALTH CENTERS (HOKENJO) IN TUBERCULOSIS CONTROL IN JAPAN.

Authors:  Nobuyuki Katsuda; Tomoya Hirosawa; Joshua A Reyer; Nobuyuki Hamajima
Journal:  Nagoya J Med Sci       Date:  2015-02       Impact factor: 1.131

3.  Geographic prediction of tuberculosis clusters in Fukuoka, Japan, using the space-time scan statistic.

Authors:  Daisuke Onozuka; Akihito Hagihara
Journal:  BMC Infect Dis       Date:  2007-04-11       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.